Biosante Pharmaceuticals shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Biosante Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Biosante Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Biosante Pharmaceuticals by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $2.3M | 41k | 55.14 |
| 2023-09-30 | $2.3M | 39k | 58.06 |
| 2023-06-30 | $3.9M | 73k | 53.83 |
| 2023-03-31 | $2.7M | 67k | 39.72 |
| 2022-12-31 | $2.9M | 72k | 40.23 |
| 2022-06-30 | $4.0M | 136k | 29.67 |
| 2022-03-31 | $439k | 16k | 28.09 |
| 2021-12-31 | $1.8M | 38k | 46.10 |
| 2021-09-30 | $10M | 311k | 32.81 |
| 2021-03-31 | $12M | 338k | 36.13 |
| 2020-12-31 | $9.9M | 343k | 29.03 |
| 2020-09-30 | $8.8M | 312k | 28.23 |
| 2020-06-30 | $8.9M | 274k | 32.36 |
| 2019-12-31 | $17M | 279k | 61.67 |
| 2019-09-30 | $16M | 225k | 72.88 |
| 2019-06-30 | $3.8M | 46k | 82.21 |
| 2019-03-31 | $3.9M | 55k | 70.55 |
| 2018-12-31 | $2.3M | 52k | 45.03 |
| 2018-09-30 | $5.9M | 105k | 56.53 |
| 2018-06-30 | $6.3M | 94k | 66.81 |
| 2018-03-31 | $4.8M | 82k | 58.22 |
| 2017-12-31 | $2.3M | 35k | 64.47 |
| 2017-09-30 | $2.3M | 44k | 52.49 |
| 2017-06-30 | $760k | 16k | 46.79 |
| 2017-03-31 | $1.0M | 21k | 49.52 |
| 2016-12-31 | $1.4M | 24k | 60.61 |
| 2016-09-30 | $836k | 13k | 66.32 |
| 2016-06-30 | $535k | 9.6k | 55.80 |
| 2016-03-31 | $535k | 16k | 33.67 |
| 2015-12-31 | $562k | 13k | 45.12 |
| 2015-09-30 | $380k | 9.6k | 39.55 |
| 2015-06-30 | $1.8M | 29k | 62.04 |
| 2015-03-31 | $1.1M | 18k | 62.52 |
| 2014-03-31 | $259k | 8.2k | 31.40 |